Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination coverage against COVID-19 among people living with HIV infection in the Czech Republic.

Central European journal of public health·2026
Same author

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

HIV research & clinical practice·2026
Same author

[Current state of HIV treatment].

Klinicka mikrobiologie a infekcni lekarstvi·2026
Same authorSame journal

[Assessing the nutritional status of treated HIV-positive individuals].

Klinicka mikrobiologie a infekcni lekarstvi·2026
Same author

Unmasking the impact of cytomegalovirus reactivation in people with advanced HIV disease with <i>Pneumocystis Jirovecii</i> pneumonia: does antiviral therapy change outcomes?

HIV research & clinical practice·2026
Same author

Corrigendum to "Demographic, epidemiological and clinical characteristics of Ukrainian war refugees with HIV infection in the Slovak Republic" [Travel Med Infect Dis 62 (2024) 102764].

Travel medicine and infectious disease·2024

Related Experiment Video

Updated: Jun 18, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

[HIV retinopathy].

Pavel Kozner1, Ladislav Machala, Hanus Rozsypal

  • 1Eye Department, The Faculty Hospital Na Bulovce Faculty, Prague, Czech Republic.

Klinicka Mikrobiologie a Infekcni Lekarstvi
|November 17, 2009
PubMed
Summary
This summary is machine-generated.

HIV retinopathy, an eye condition in advanced HIV infection, is generally benign but requires differentiation from sight-threatening conditions. It signals potential HIV progression, warranting consideration for antiretroviral therapy.

More Related Videos

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Immunology

Context:

  • HIV retinopathy is an ocular manifestation primarily affecting individuals with advanced HIV infection and significant immunodeficiency.
  • Distinguishing HIV retinopathy from other potentially sight-damaging ocular conditions, such as Cytomegalovirus (CMV) retinitis, is crucial for appropriate patient management.

Purpose:

  • To highlight the clinical significance of HIV retinopathy.
  • To emphasize the importance of differential diagnosis in HIV-positive patients with ocular symptoms.
  • To underscore the role of HIV retinopathy as an indicator for initiating antiretroviral therapy.

Summary:

  • HIV retinopathy is a common, typically benign ocular finding in patients with severe HIV-induced immunodeficiency.
  • While not requiring direct treatment, it necessitates careful evaluation to rule out more severe ocular pathologies like CMV retinitis.
  • Its presence serves as a critical clinical sign of HIV disease progression, prompting consideration for antiretroviral therapy in previously untreated individuals.

Impact:

  • Facilitates accurate diagnosis and management of ocular complications in HIV patients.
  • Contributes to timely initiation of antiretroviral therapy, potentially slowing HIV progression.
  • Improves visual health outcomes for individuals living with HIV.